Login
Products
Login
Home
Alerts
Search
Watchlists
Products

DMCC Speciality Chemicals Ltd

DMCC
NSE
285.17
0.38%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

DMCC Speciality Chemicals Ltd

DMCC
NSE
285.17
0.38%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
711Cr
Close
Close Price
285.17
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
27.21
PS
Price To Sales
1.34
Revenue
Revenue
529Cr
Rev Gr TTM
Revenue Growth TTM
35.66%
PAT Gr TTM
PAT Growth TTM
25.60%
Peer Comparison
How does DMCC stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DMCC
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
978677818485103118125127126151
Growth YoY
Revenue Growth YoY%
-5.1-24.5-26.911.8-13.0-0.334.346.649.148.922.727.8
Expenses
ExpensesCr
80756773777687100110110112136
Operating Profit
Operating ProfitCr
16119779151815171415
OPM
OPM%
16.912.812.48.88.810.414.915.012.113.311.19.8
Other Income
Other IncomeCr
111190000000
Interest Expense
Interest ExpenseCr
333443332222
Depreciation
DepreciationCr
544444444444
PBT
PBTCr
95409291191189
Tax
TaxCr
321031333333
PAT
PATCr
732061686866
Growth YoY
PAT Growth YoY%
80.8-49.6183.8109.8-13.8-56.4145.22,438.712.1466.4-1.0-21.6
NPM
NPM%
6.93.73.10.46.91.65.76.75.26.14.64.1
EPS
EPS
2.71.30.90.12.30.62.33.22.63.12.32.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
175178228188200326385328431529
Growth
Revenue Growth%
1.727.7-17.56.763.017.9-14.831.522.7
Expenses
ExpensesCr
146155174160165286351292374468
Operating Profit
Operating ProfitCr
30235428354134365761
OPM
OPM%
16.912.923.514.817.712.58.811.113.211.5
Other Income
Other IncomeCr
11168651011
Interest Expense
Interest ExpenseCr
5432251114118
Depreciation
DepreciationCr
44567818161716
PBT
PBTCr
21164726343411173137
Tax
TaxCr
431-6113461011
PAT
PATCr
1712463133217122226
Growth
PAT Growth%
-27.9275.3-31.83.5-34.5-67.567.285.821.5
NPM
NPM%
9.76.920.316.816.36.51.83.55.04.9
EPS
EPS
6.94.918.512.613.18.62.84.78.610.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
25252525252525252525
Reserves
ReservesCr
354891120148169173185203209
Current Liabilities
Current LiabilitiesCr
7160534769127132107110107
Non Current Liabilities
Non Current LiabilitiesCr
18242020226370614333
Total Liabilities
Total LiabilitiesCr
149157188212264384401377380375
Current Assets
Current AssetsCr
6065879991126137115135140
Non Current Assets
Non Current AssetsCr
8992102112172258264262245235
Total Assets
Total AssetsCr
149157188212264384401377380375

Cash Flow

Consolidated
Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
291821273251303838
Investing Cash Flow
Investing Cash FlowCr
-8-9-13-17-40-98-21-10-7
Financing Cash Flow
Financing Cash FlowCr
-19-9-8-6345-10-27-30
Net Cash Flow
Net Cash FlowCr
2005-4-2-112
Free Cash Flow
Free Cash FlowCr
2210710-10-4791931
CFO To PAT
CFO To PAT%
170.1149.445.285.899.0239.6431.1331.1176.7
CFO To EBITDA
CFO To EBITDA%
97.780.239.097.090.8125.888.1105.866.7

Ratios

Consolidated
Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
209237366169793908598684749
Price To Earnings
Price To Earnings
14.019.27.95.424.442.586.359.034.8
Price To Sales
Price To Sales
1.21.31.60.94.02.81.62.11.7
Price To Book
Price To Book
4.03.33.21.24.64.73.03.33.3
EV To EBITDA
EV To EBITDA
7.711.07.16.423.024.220.020.613.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.940.648.750.753.339.535.638.938.0
OPM
OPM%
16.912.923.514.817.712.58.811.113.2
NPM
NPM%
9.76.920.316.816.36.51.83.55.0
ROCE
ROCE%
30.720.937.217.118.214.27.611.315.2
ROE
ROE%
28.516.939.921.718.811.03.55.59.5
ROA
ROA%
11.47.824.514.812.35.61.73.15.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **1. Bulk Chemicals** - **Products:** Sulphuric Acid, Oleum, Chloro Sulphonic Acid, Sulphuric Anhydride (SO₃). - **Sales Profile:** ~50% domestic (regionally distributed), 50% captive use for downstream specialty chemicals. - **Capacity & Utilization:** Operating near full capacity (>90%), particularly in sulphuric acid production. - **Market Dynamics:** Commodity-driven with low margins, high price sensitivity, and dependence on logistics and consistent raw material supply. - **Recent Developments:** - A large copper smelter commissioning in Gujarat is expected to increase domestic sulphuric acid supply, likely leading to **near-term price softening**. - The Roha plant faces a **planned maintenance shutdown in Q1 FY26**, which may impact short-term performance. ### **2. Specialty Chemicals** - **Products:** Benzene Sulphonate, Phenol Sulphonate, Sulphones, Sodium Vinyl Sulphonate, Diphenyl Sulphone, and downstream sulphur- and boron-based derivatives. - **Sales Profile:** 65–70% of specialty products are **export-oriented**. - **Applications:** Pharmaceuticals, agrochemicals, dyes, detergents, pigments, coatings, cosmetics, and ceramics. - **Segment Evolution:** - Specialty chemicals accounted for **~44–52% of total revenue in recent years**, depending on cyclical demand. - The segment has faced **two years of weak demand** due to European destocking, high energy costs, and inflation, leading to **low capacity utilization (50–85%)** and margin pressure. - Signs of recovery are emerging as customer inventories normalize. --- ## **Key Strategic Developments (2025–2026)** ### **1. Commercial & Export Growth** - **New Export Opportunities:** DMCC sees **strong export potential in niche, low-volume sulfonation products** in **APAC and LATAM**, driven by Chinese manufacturers moving downstream and reducing their supply in these segments. - **Geographic Rebalancing:** The company is **reducing reliance on European exports** (which declined from ~60% to under 20% of exports) and **expanding in US, Latin America, and China markets**. - **Resilience Amid Tariffs:** Despite U.S. tariffs, the company has retained all major export customers—indicating **pricing resilience, product differentiation, and strong customer trust** in key markets. ### **2. Production & Capacity** - **Facilities Summary:** | Facility | Location | Area | Focus | Capacity | Key Features | |--------|--------|------|-------|----------|-------------| | Roha | Maharashtra | 88,355 sq. m. | Sulphur Chemistry | 350 TPD Sulphuric Acid | R&D center, zero liquid discharge (ZLD), 3 multi-purpose plants, land reserves for future expansion | | Dahej | Gujarat | 103,327 sq. m. | Sulphur & Boron Chemistry | Expanding capacity | Closer to suppliers, lower logistics cost, ZLD planned, 50% land reserved for growth | - **Dahej Plant Expansion:** Near completion, it will drive **revenue and margin growth** from higher-margin specialty chemicals and improve logistics efficiency. - **Underutilized Capacity:** Both sites currently have **ample capacity** to scale quickly as demand recovers—critical for capitalizing on rebound opportunities. ### **3. R&D & Innovation** - **R&D Center:** Located at Roha and expanding to Dahej; **recognized by CSIR and DSIR**, India. - **Investment:** ₹1.09 crores in FY24; historically increased to ₹2.25 crores in FY20 (40% YoY growth). - **Focus Areas:** - Process optimization and cost reduction. - Development of high-value, low-volume specialty chemicals. - Exploration of **advanced reactor technologies (e.g., flow reactors)** to improve yield and safety. - Innovation in **boron chemistry** (e.g., Zinc Borate, Trimethyl Borate) and **pharmaceutical intermediates** (Sulfones, Thiols, Amides). - **Commercialization Model:** Full lifecycle integration—from lab to production—with **pilot plants enabling rapid scale-up** and **customer-specific solutions**. ### **4. Boron Chemistry Growth** - **Products:** Boric Acid, Borax Pentahydrate, Borax Decahydrate, Zinc Borate, Disodium Octaborate, Trimethyl Borate. - **Market Applications:** Ceramics, detergents, electroplating, steel, and **automotive fluids** (new product under development). - **Strategic Move:** DMCC is investing in **backward integration and debottlenecking** at its boron facility to reduce costs and enhance production reliability. - **Financials:** Boron segment generates ~₹100 crore annually and operates near full capacity. --- ## **Financial & Operational Strengths** - **Revenue Composition (Recent Period):** - **56% Bulk Chemicals** - **44% Specialty Chemicals** - **Exports:** 18–27% of total turnover (down from earlier highs due to weaker European demand). - **Strong Margins & Resilience:** - **Long-term contracts with cost pass-through clauses** (1-quarter lag) protect margins from raw material volatility. - **Backward integration** improves cost control and supply chain resilience. - **Financial Position:** - **Minimal debt** (long-term borrowings < ₹60 crores). - **No major capex planned**; previous investments complete. - **Disciplined approach to expansion**: Requires 70–80% utilization and strong demand before scaling. - **Target revenue from current assets:** ~₹500 crores under existing conditions. --- ## **Competitive Advantages** - **Over 100 Years of Expertise:** Deep technical knowledge in **sulfur chemistry** and **hazardous chemical handling**. - **High Barriers to Entry:** - Complex and hazardous chemical processes. - Lengthy customer approval cycles (6–18 months), leading to **durable, sticky relationships**. - Strong **regulatory compliance and safety record**. - **Backward Integration:** Makes DMCC a **low-cost global producer** of key specialty chemicals. - **Strategic Location:** Dahej’s proximity to key suppliers reduces logistics costs and enhances competitiveness. - **Flexible Manufacturing Infrastructure:** Mix of **dedicated and multipurpose plants** enables rapid introduction of new products with minimal capital outlay.